Fast-track-submission_PIA_PI-Survey - Final (Revised)

Request for Approval under the “Generic Clearance for the Collection of Routine Customer Feedback” (OMB Control Number: 0925-0668)

T ITLE OF INFORMATION COLLECTION:

Grantees’ Perceptions Regarding the NIAID DAIDS Phased Innovation Award (R21/R33) Funding Mechanism

PURPOSE:

The Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID) has utilized the biphasic R21/R33 grant mechanism to support AIDS Vaccine Research and the Microbicide Innovation Program. NIAID DAIDS is interested in knowing grantees’ overall satisfaction with the Phased Innovation Award R21/R33 grant funding mechanism. It is also of interest to obtain information regarding key aspects of the funding mechanism that were particularly helpful or challenging. This survey is part of a customer satisfaction assessment to examine the NIAID DAIDS Phased Innovation Award Program implementation and grantees’ perceptions to date.

DESCRIPTION OF RESPONDENTS:

Potential survey respondents are the Principal Investigators (PIs) who received NIAID DAIDS AIDS Vaccine Research (AVR) or Microbicide Innovation Program (MIP) phased innovation awards from FY 2006 through FY 2012. A total of 76 applicants received an award under this R21/R33 funding mechanism.

TYPE OF COLLECTION: (Check one)

[ ] Customer Comment Card/Complaint Form [X] Customer Satisfaction Survey

[ ] Usability Testing (e.g., Website or Software) [ ] Small Discussion Group

[ ] Focus Group [ ] Other: ______________________

CERTIFICATION:

I certify the following to be true:

1. The collection is voluntary.

2. The collection is low-burden for respondents and low-cost for the Federal Government.

3. The collection is non-controversial and does not raise issues of concern to other federal agencies.

4. The results are not intended to be disseminated to the public.

5. Information gathered will not be used for the purpose of substantially informing influential policy decisions.

6. The collection is targeted to the solicitation of opinions from respondents who have experience with the program or may have experience with the program in the future.

Name: Madelon Halula, PhD

DHHS, NIH, NIAID, DAIDS

To assist review, please provide answers to the following question:

Personally Identifiable Information:

1. Is personally identifiable information (PII) collected? [ ] Yes [X] No

2. If Yes, will any information that is collected be included in records that are subject to the Privacy Act of 1974? [ ] Yes [ ] No

3. If Yes, has an up-to-date System of Records Notice (SORN) been published? [ ] Yes [ ] No

Gifts or Payments:

Is an incentive (e.g., money or reimbursement of expenses, token of appreciation) provided to participants? [ ] Yes [ X] No

BURDEN HOURS

Category of Respondent	No. of Respondents	Participation Time	Burden
Private Sector (Academia)	76	15 minutes	19.00 h
Totals	76	15 minutes	19.00 h

FEDERAL COST: The estimated annual cost to the Federal government is a $0 one-time cost.

If you are conducting a focus group, survey, or plan to employ statistical methods, please provide answers to the following questions:

The selection of your targeted respondents

1. Do you have a customer list or something similar that defines the universe of potential respondents and do you have a sampling plan for selecting from this universe? [X] Yes [ ] No

If the answer is yes, please provide a description of both below (or attach the sampling plan)? If the answer is no, please provide a description of how you plan to identify your potential group of respondents and how you will select them?

The universe of potential respondents is the Principal Investigators (PIs) who received AIDS Vaccine Research or Microbicide Innovations Program phased innovation awards from FY 2006 through FY 2012. We intend to invite all 76 PIs to complete the survey and we expect a 90% response rate, giving us 68 PIs who actually complete the survey.

Administration of the Instrument

1. How will you collect the information? (Check all that apply)

[ X] Web-based or other forms of Social Media

[ ] Telephone

[ ] In-person

[ ] Mail

[ ] Other, Explain

2. Will interviewers or facilitators be used? [ ] Yes [ X] No

2